Ann: Clinical Trial update - March quarter, page-4

Just sort of bobbing along with no real excitement in the announcements. I suppose its just a case of wait and see.
They may struggle to convince investors to take up their rights issue as there are a lot of small caps looking for cash and FTT have had a long time to get this product to market and are not hitting the targets they set for themselves. Im staying in but its been 7 years and $300k in the red, since buying in and my resolve is weakening.